F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SPP2 | Secreted phosphoprotein 2, 24kDa | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFHR2 | Complement factor H-related 2 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
F9 | Coagulation factor IX | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
MBL2 | Mannose-binding lectin (protein C) 2, soluble | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4 | Apolipoprotein C-IV | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C9 | Complement component 9 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFHR5 | Complement factor H-related 5 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINC1 | Serpin peptidase inhibitor, clade C (antithrombin), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC10A1 | Solute carrier family 10 (sodium/bile acid cotransporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLCO1B1 | Solute carrier organic anion transporter family, member 1B1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CYP2A6 | Cytochrome P450, family 2, subfamily A, polypeptide 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOA2 | Apolipoprotein A-II | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP1A2 | Cytochrome P450, family 1, subfamily A, polypeptide 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
APOA5 | Apolipoprotein A-V | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINA11 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFHR4 | Complement factor H-related 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINA10 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINA7 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AL590714.1 | Uncharacterized protein | | | | | | Tissue enriched |
ITIH1 | Inter-alpha-trypsin inhibitor heavy chain 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TAT | Tyrosine aminotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
HAO1 | Hydroxyacid oxidase (glycolate oxidase) 1 | Enzymes
| | | | | Tissue enriched |
UROC1 | Urocanate hydratase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
ITIH2 | Inter-alpha-trypsin inhibitor heavy chain 2 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC22A10 | Solute carrier family 22, member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SERPIND1 | Serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC22A1 | Solute carrier family 22 (organic cation transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC25A47 | Solute carrier family 25, member 47 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
FGB | Fibrinogen beta chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOH | Apolipoprotein H (beta-2-glycoprotein I) | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFHR3 | Complement factor H-related 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SAA4 | Serum amyloid A4, constitutive | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FGA | Fibrinogen alpha chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ORM2 | Orosomucoid 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GBP7 | Guanylate binding protein 7 | | | | | | Tissue enriched |
FGG | Fibrinogen gamma chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
GDF2 | Growth differentiation factor 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
RDH16 | Retinol dehydrogenase 16 (all-trans) | Predicted membrane proteins
| | | | | Tissue enriched |
APOF | Apolipoprotein F | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HP | Haptoglobin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
F13B | Coagulation factor XIII, B polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC17A2 | Solute carrier family 17, member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
HRG | Histidine-rich glycoprotein | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
PLGLB2 | Plasminogen-like B2 | Predicted secreted proteins
| | | | | Tissue enriched |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP2C8 | Cytochrome P450, family 2, subfamily C, polypeptide 8 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC22A9 | Solute carrier family 22 (organic anion transporter), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |